Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.
Google ScholarÂ
Wong MCS, Huang J, Chan PSF, Choi P, Lao XQ, Chan SM, et al. Global incidence and mortality of gastric cancer, 1980–2018. JAMA Netw Open. 2021;4:e2118457.
Google ScholarÂ
Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet. 2016;388:2654–64.
Google ScholarÂ
Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71:264–79.
Google ScholarÂ
Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16:57.
Google ScholarÂ
Shin WS, Xie F, Chen B, Yu P, Yu J, To KF, et al. Updated epidemiology of gastric cancer in Asia: decreased incidence but still a big challenge. Cancers. 2023;15:9.
Reticker-Flynn NE, Zhang W, Belk JA, Basto PA, Escalante NK, Pilarowski GOW, et al. Lymph node colonization induces tumor-immune tolerance to promote distant metastasis. Cell. 2022;185:1924–42.e23.
Google ScholarÂ
Lin Y, Shao Q, Zhang F, Huang Z. Historical evolution and current research status of lymph node staging in gastric cancer: a review. World J Surg Oncol. 2025;23:338.
Google ScholarÂ
Miciak M, Jurkiewicz K, Dzierżek P, Rudno-Rudzińska J, Kielan W. Prognostic significance of Lymph Node Ratio (LNR) in gastric cancer in predicting postoperative complications and survival: a single-center study. Cancers. 2025;17:743.
Li P, Zhang H, Chen T, Zhou Y, Yang J, Zhou J. Cancer-associated fibroblasts promote proliferation, angiogenesis, metastasis and immunosuppression in gastric cancer. Matrix Biol: J Int Soc Matrix Biol. 2024;132:59–71.
Google ScholarÂ
Zhao JJ, Ong CJ, Srivastava S, Chia DKA, Ma H, Huang K, et al. Spatially resolved niche and tumor microenvironmental alterations in gastric cancer peritoneal metastases. Gastroenterology. 2024;167:1384–98.e4.
Google ScholarÂ
Gan L, Meng J, Xu M, Liu M, Qi Y, Tan C, et al. Extracellular matrix protein 1 promotes cell metastasis and glucose metabolism by inducing integrin β4/FAK/SOX2/HIF-1α signaling pathway in gastric cancer. Oncogene. 2018;37:744–55.
Google ScholarÂ
Andreuzzi E, Capuano A, Poletto E, Pivetta E, Fejza A, Favero A, et al. Role of extracellular matrix in gastrointestinal cancer-associated Angiogenesis. Int J Mol Sci. 2020;21:3686.
Huang Y, Xu X, Lu Y, Sun Q, Zhang L, Shao J, et al. The phase separation of extracellular matrix protein matrilin-3 from cancer-associated fibroblasts contributes to gastric cancer invasion. FASEB J. 2024;38:e23406.
Google ScholarÂ
Domogatskaya A, Rodin S, Tryggvason K. Functional diversity of laminins. Annu Rev Cell Dev Biol. 2012;28:523–53.
Google ScholarÂ
Guess CM, Quaranta V. Defining the role of laminin-332 in carcinoma. Matrix Biol. 2009;28:445–55.
Google ScholarÂ
Litjens SH, de Pereda JM, Sonnenberg A. Current insights into the formation and breakdown of hemidesmosomes. Trends Cell Biol. 2006;16:376–83.
Google ScholarÂ
Nishiuchi R, Takagi J, Hayashi M, Ido H, Yagi Y, Sanzen N, et al. Ligand-binding specificities of laminin-binding integrins: a comprehensive survey of laminin-integrin interactions using recombinant alpha3beta1, alpha6beta1, alpha7beta1 and alpha6beta4 integrins. Matrix Biol. 2006;25:189–97.
Google ScholarÂ
Choma DP, Pumiglia K, DiPersio CM. Integrin alpha3beta1 directs the stabilization of a polarized lamellipodium in epithelial cells through activation of Rac1. J Cell Sci. 2004;117:3947–59.
Google ScholarÂ
Rousselle P, Keene DR, Ruggiero F, Champliaud MF, Rest M, Burgeson RE. Laminin 5 binds the NC-1 domain of type VII collagen. J Cell Biol. 1997;138:719–28.
Google ScholarÂ
Waterman EA, Sakai N, Nguyen NT, Horst BA, Veitch DP, Dey CN, et al. A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3-kinase activation. Cancer Res. 2007;67:4264–70.
Google ScholarÂ
Jung SN, Lim HS, Liu L, Chang JW, Lim YC, Rha KS, et al. LAMB3 mediates metastatic tumor behavior in papillary thyroid cancer by regulating c-MET/Akt signals. Sci Rep. 2018;8:2718.
Google ScholarÂ
Zhou Y, Dang J, Chang KY, Yau E, Aza-Blanc P, Moscat J, et al. miR-1298 inhibits mutant KRAS-driven tumor growth by repressing FAK and LAMB3. Cancer Res. 2016;76:5777–87.
Google ScholarÂ
Pan Z, Li L, Fang Q, Zhang Y, Hu X, Qian Y, et al. Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression. Cancer Cell Int. 2018;18:214.
Google ScholarÂ
Zhang J, Li Y, Liu H, Zhang J, Wang J, Xia J, et al. Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis. J Exp Clin Cancer Res. 2022;41:24.
Google ScholarÂ
Zhang F, Virshup DM, Cheong JK. Oncogenic RAS-induced CK1α drives nuclear FOXO proteolysis. Oncogene. 2018;37:363–76.
Google ScholarÂ
Zhang H, Pan YZ, Cheung M, Cao M, Yu C, Chen L, et al. LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K/Akt signaling pathway. Cell Death Dis. 2019;10:230.
Google ScholarÂ
Zhu Z, Song J, Guo Y, Huang Z, Chen X, Dang X, et al. LAMB3 promotes tumour progression through the AKT-FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer. Oncogene. 2020;39:4666–80.
Google ScholarÂ
Kwon OH, Park JL, Kim M, Kim JH, Lee HC, Kim HJ, et al. Aberrant up-regulation of LAMB3 and LAMC2 by promoter demethylation in gastric cancer. Biochem Biophys Res Commun. 2011;406:539–45.
Google ScholarÂ
Ii M, Yamamoto H, Taniguchi H, Adachi Y, Nakazawa M, Ohashi H, et al. Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer. Int J Oncol. 2011;39:593–9.
Google ScholarÂ
Wang Y, Fan X, Song Y, Liu Y, Liu R, Wu J, et al. SAMD4 family members suppress human hepatitis B virus by directly binding to the Smaug recognition region of viral RNA. Cell Mol Immunol. 2020;18:1032–44.
Google ScholarÂ
Semotok JL, Cooperstock RL, Pinder BD, Vari HK, Lipshitz HD, Smibert CA. Smaug recruits the CCR4/POP2/NOT deadenylase complex to trigger maternal transcript localization in the early Drosophila embryo. Curr Biol: CB. 2005;15:284–94.
Google ScholarÂ
Theocharis AD, Skandalis SS, Gialeli C, Karamanos NK. Extracellular matrix structure. Adv Drug Deliv Rev. 2016;97:4–27.
Google ScholarÂ
Qin Y, Rodin S, Simonson OE, Hollande F. Laminins and cancer stem cells: Partners in crime? Semin Cancer Biol. 2017;45:3–12.
Google ScholarÂ
Wang Y, Li G, Wang Z, Wang W, Wang X, Luo X, et al. Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer. Front Mol Biosci. 2023;10:1157970.
Google ScholarÂ
Lai YW, Liu ZW, Lin MH, Yang CC, Chu CY, Chung CH, et al. Melatonin increases Olaparib sensitivity and suppresses cancer-associated fibroblast infiltration via suppressing the LAMB3-CXCL2 axis in TNBC. Pharmacol Res. 2024;209:107429.
Google ScholarÂ
Lin H, Yang P, Li B, Chang Y, Chen Y, Li Y, et al. S100A10 promotes pancreatic ductal adenocarcinoma cells proliferation, migration and adhesion through JNK/LAMB3-LAMC2 Axis. Cancers. 2022;15:202.
Chen E, Wang Q, Wang L, Huang Z, Yang D, Zhao C, et al. NAT10 regulates tumor progression and immune microenvironment in pancreatic ductal adenocarcinoma via the N4-acetylated LAMB3-mediated FAK/ERK pathway. Cancer Commun. 2025;45:1162–87.
Ma D, Liu S, Liu K, Kong L, Xiao L, Xin Q, et al. MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway. Cancer Biol Ther. 2024;25:2314324.
Google ScholarÂ
Xie BW, Guan B, Chen W, Zhou M, Gu Q, Liu Y, et al. Tumor-derived extracellular vesicles delivering TNF-α promotes colorectal cancer metastasis via the NF-kB/LAMB3/AKT axis by targeting SNAP23. Arch Biochem Biophys. 2023;741:109605.
Google ScholarÂ
Brognard J, Newton AC. PHLiPPing the switch on Akt and protein kinase C signaling. Trends Endocrinol Metab: TEM. 2008;19:223–30.
Google ScholarÂ
Newton AC, Trotman LC. Turning off AKT: PHLPP as a drug target. Annu Rev Pharmacol Toxicol. 2014;54:537–58.
Google ScholarÂ
Shi X, Yang J, Liu M, Zhang Y, Zhou Z, Luo W, et al. Circular RNA ANAPC7 INHIBITS TUMOR GROWTH AND MUSCLE WASTIng via PHLPP2-AKT-TGF-β signaling axis in pancreatic cancer. Gastroenterology. 2022;162:2004–17.e2.
Google ScholarÂ
Jin H, Ma J, Xu J, Li H, Chang Y, Zang N, et al. Oncogenic role of MIR516A in human bladder cancer was mediated by its attenuating PHLPP2 expression and BECN1-dependent autophagy. Autophagy. 2021;17:840–54.
Google ScholarÂ
Nowak DG, Katsenelson KC, Watrud KE, Chen M, Mathew G, D’Andrea VD, et al. The PHLPP2 phosphatase is a druggable driver of prostate cancer progression. J Cell Biol. 2019;218:1943–57.
Google ScholarÂ
Tantai J, Pan X, Chen Y, Shen Y, Ji C. TRIM46 activates AKT/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells. Cell Death Dis. 2022;13:285.
Google ScholarÂ
Aviv T, Lin Z, Lau S, Rendl LM, Sicheri F, Smibert CA. The RNA-binding SAM domain of Smaug defines a new family of post-transcriptional regulators. Nat Struct Biol. 2003;10:614–21.
Google ScholarÂ
Wang X-Y, Zhang L-N RNA-binding protein SAMD4: current knowledge and future perspectives. Cell Biosci. 2023;13:21.
Wu L, Zhang F, Chen H, Zhao G LSM12 promotes the lung squamous cell carcinoma progression through mediating alternative splicing of ARRB1. Commun Biol. 2025;8:814.
Zhou M, Wang B, Li H, Han J, Li A, Lu W. RNA-binding protein SAMD4A inhibits breast tumor angiogenesis by modulating the balance of angiogenesis program. Cancer Sci. 2021;112:3835–45.
Google ScholarÂ
Chen X, Yang C, Wang W, He X, Sun H, Lyu W, et al. Exploration of prognostic genes and risk signature in breast cancer patients based on RNA-binding proteins associated with ferroptosis. Front Genet. 2023;14:1025163.
Google ScholarÂ
Januchowski R, Sterzyńska K, Zawierucha P, Ruciński M, Świerczewska M, Partyka M, et al. Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines. Oncotarget. 2017;8:49944–58.
Google ScholarÂ
Li D, Qi T, Chen J. SAMD4A serves as a negative prognostic marker for gastric cancer patients. Tissue cell. 2023;84:102167.
Google ScholarÂ
